VYNE Therapeutics
VYNE
#10149
Rank
HK$0.15 B
Marketcap
HK$4.67
Share price
48.99%
Change (1 day)
-77.25%
Change (1 year)

VYNE Therapeutics (VYNE) - Total debt

Total debt on the balance sheet as of September 2025 : N/A

According to VYNE Therapeutics's latest financial reports the company's total debt is N/A. A companyโ€™s total debt is the sum of all current and non-current debts.

VYNE Therapeutics - Total debt on balance sheet (from 2018 to 2025)

Total debt by year

Year Total debt Change
2024-12-31HK$0.76 M-54.01%
2023-12-31HK$1.67 M
2022-12-31N/A-100%
2021-12-31HK$2.72 M-98.99%
2020-12-31HK$0.26 B4846.22%
2019-12-31HK$5.45 M
2018-12-31N/A

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
ORIC Pharmaceuticals
ORIC
HK$25.67 MN/A๐Ÿ‡บ๐Ÿ‡ธ USA